CARB FENCE
LIVE

Serial Number

79406956

Owner

Sigrid Therapeutics AB

Attorney

Bradley L. Cohn

Filing Date

Jun 25, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CARB FENCE Trademark

Serial Number: 79406956 • Registration: 8097714

CARB FENCE is a trademark filed by Sigrid Therapeutics AB on June 25, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Sigrid Therapeutics AB (5 trademarks)

Birger Jarlsgatan 57

Entity Type: 98

Trademark Details

Filing Date

June 25, 2024

Registration Date

January 13, 2026

Published for Opposition

November 25, 2025

Goods & Services

Surgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health and for use in weight control; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health and for use in weight control; medical devices for treatment of prediabetes, diabetes and glycaemic control, and for the improvement of overall metabolic health and for use in weight control; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health and for use in weight control; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients

Dietetic preparations adapted for medical use; dietetic food adapted for medical use; pharmaceutical preparations for use in naturopathy; nutritional supplements; pharmaceutical preparations for treating diabetes; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and food for glycemic control adapted for medical use; dietetic preparations and food for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances, and medicine in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances, and medicine in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; pharmaceutical preparations and natural remedy preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemical pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and food for glycemic control; dietetic preparations and food for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, and dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients; dietary supplements for humans; dietary supplements for the support of healthy blood sugar levels, weight levels, cholesterol levels, blood pressure levels, and energy levels; vitamin supplements; mineral supplements; food supplements; dietary and nutritional supplements for animals; nutritional additives to foodstuffs for animals, for medical purposes in the nature of dietary supplements; vitamin supplements for animals; mineral dietary supplements for animals; antibiotic food supplements for animals; medicated supplements for foodstuffs for animals; pharmaceutical preparations, food, and nutritional supplements for animals, for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations, food, and nutritional supplements for animals, for weight loss, weight management, prevention and treatment of obesity; pharmaceutical preparations, food and nutritional supplements for animals, for the treatment and regulation of body fat, cholesterol and LDL cholesterol levels, blood lipids and gut microbiota; pharmaceutical preparations for use as additives to food for human consumption for medical purposes.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 6, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 18, 2026 FICS
FINAL DISPOSITION PROCESSED
Jul 18, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 13, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 2, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 16, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 16, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 13, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 13, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 7, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 7, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 2, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 2, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 2, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2025 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 18, 2025 ADCH
REFUSAL PROCESSED BY IB
Mar 15, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 26, 2025 RFCS
REFUSAL PROCESSED BY MPU
Feb 26, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 11, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 10, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 23, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 18, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 18, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 17, 2024 REPR